Balancing Safety and Efficacy of Epidermal Growth Factor Receptor Inhibitors in Patients With Squamous Cell Carcinoma of the Head and Neck

The epidermal growth factor receptor (EGFR) is overexpressed in more than 80% of squamous cell cancers of the head and neck (SCCHN). An evolving understanding of the role of EGFR in tumorigenesis has made the receptor an important therapeutic target in SCCHN. Several EGFR inhibitors (EGFRIs) are act...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncologist
Hlavní autoři: Iberri, David J., Colevas, A. Dimitrios
Médium: Artigo
Jazyk:Inglês
Vydáno: AlphaMed Press 2015
Témata:
Head and Neck Cancers
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4679082/
https://ncbi.nlm.nih.gov/pubmed/26446236
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0177
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky